Literature DB >> 2983082

The circular intracellular form of Epstein-Barr virus DNA is amplified by the virus-associated DNA polymerase.

J E Shaw.   

Abstract

Selective DNA extraction and hybridization procedures were used to estimate the relative number of covalently closed circular viral genomes in cultures of Epstein-Barr virus (EBV)-transformed cells. In virus-producing P3HR-1 cultures that were exposed for 11 days to phosphonoacetic acid or to acyclovir, the content of covalently closed circular EBV DNA was reduced ca. 70% relative to a control culture without drug. The EBV plasmid content of Raji, a virus nonproducer cell line, was not reduced by exposure to these compounds. When P3HR-1 cultures were exposed to 12-O-tetradecanoylphorbol-13-acetate, the number of circular genomes per cell increased. These findings indicate that two enzyme activities synthesize circular EBV DNA and that the virus-associated DNA polymerase synthesizes most of the circular EBV DNA in a virus producer culture. It is suggested that the circular genomes synthesized by the viral enzyme are intermediates in the syntheses of linear virus DNA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983082      PMCID: PMC254746     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

2.  Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.

Authors:  T Lindahl; A Adams; G Bjursell; G W Bornkamm; C Kaschka-Dierich; U Jehn
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

3.  Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.

Authors:  W C Summers; G Klein
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

4.  Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid.

Authors:  Y Yajima; A Tanaka; M Nonoyama
Journal:  Virology       Date:  1976-05       Impact factor: 3.616

5.  Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.

Authors:  A Adams; T Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

6.  Complexity of EBV homologous DNA in continous lymphoblastoid cell lines.

Authors:  R Pritchett; M Pendersen; E Kieff
Journal:  Virology       Date:  1976-10-01       Impact factor: 3.616

7.  Persisting oncogenic herpesvirus induced by the tumour promotor TPA.

Authors:  H zur Hausen; F J O'Neill; U K Freese; E Hecker
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

8.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

9.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

10.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

View more
  6 in total

1.  Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines.

Authors:  H Sato; T Takimoto; S Tanaka; J Tanaka; N Raab-Traub
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure.

Authors:  S L Deshmane; N W Fraser
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.

Authors:  H Sato; T Takimoto; J S Pagano; N Raab-Traub
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Specific immune serum to the Epstein-Barr virus DNA polymerase.

Authors:  R G Petit; K Leung; J E Shaw
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

5.  Chromosomal organization of the herpes simplex virus genome during acute infection of the mouse central nervous system.

Authors:  M I Muggeridge; N W Fraser
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

6.  Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines.

Authors:  J E Shaw; L A Baglia; K Leung
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.